TREM-2 Antibodies

Santa Cruz Biotechnology delivers a wide array of TREM-2 monoclonal antibodies for research in understanding TREM-2's role in various biological processes. TREM-2 monoclonal antibodies are validated for western blotting (WB), immunoprecipitation (IP), immunofluorescence (IF), immunohistochemistry with paraffin-embedded sections (IHCP), flow cytometry (FCM), and enzyme-linked immunosorbent assay (ELISA). TREM-2, or Triggering Receptor Expressed on Myeloid Cells 2, is a crucial protein involved in the immune response and has been implicated in neurodegenerative diseases, including Alzheimer's disease. TREM-2 plays a significant role in modulating inflammation and promoting the survival of neurons, making it a key target for therapeutic interventions. Research has shown that TREM-2 expression is particularly important in microglia, where it helps regulate phagocytosis and inflammatory responses. Recent studies have highlighted TREM-2's involvement in various neurological conditions, making it an increasingly important focus of research. Understanding TREM-2's function is essential for elucidating its potential as a biomarker and therapeutic target in various pathologies. TREM-2 research using Santa Cruz Biotechnology monoclonal antibodies continues to advance scientific understanding of neurodegenerative diseases and immune system regulation.